CUAMC
SMMT icon

China Universal Asset Management Company’s Summit Therapeutics SMMT Stock Holding History

China Universal Asset Management Company’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95M Sell
133,527
-4,069
-3% -$72.2K 0.12% 135
2026
Q1 		$2.61M Buy
137,596
+16,289
+13% +$263K 0.2% 88
2025
Q4 		$2.12M Sell
121,307
-8,903
-7% -$167K 0.16% 106
2025
Q3 		$2.69M Sell
130,210
-18,952
-13% -$460K 0.22% 84
2025
Q2 		$3.17M Buy
149,162
+1,196
+0.8% +$27.3K 0.3% 68
2025
Q1 		$2.85M Sell
147,966
-8,400
-5% -$169K 0.27% 81
2024
Q4 		$2.79M Buy
156,366
+17,014
+12% +$330K 0.26% 81
2024
Q3 		$3.05M Buy
139,352
+56,879
+69% +$795K 0.34% 67
2024
Q2 		$643K Sell
82,473
-52,372
-39% -$283K 0.09% 129
2024
Q1 		$558K Buy
134,845
+53,774
+66% +$214K 0.07% 174
2023
Q4 		$212K Buy
81,071
+63,168
+353% +$130K 0.04% 199
2023
Q3 		$33.5K Buy
17,903
+8,758
+96% +$16.7K 0.01% 258
2023
Q2 		$23K Sell
9,145
-308
-3% -$562 0.01% 255
2023
Q1 		$16.5K Buy
9,453
+7,408
+362% +$20.2K 0.01% 241
2022
Q4 		$8.69K Buy
2,045
+160
+8% +$291 ﹤0.01% 242
2022
Q3 		$2K Buy
+1,885
New +$2.13K ﹤0.01% 358

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

China Universal Asset Management Company's SMMT Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Summit Therapeutics (SMMT) stake by 3% in Q2 2026, selling an estimated $72.2K and leaving 133,527 shares worth $1.95M. The position accounts for 0.12% of the portfolio, ranked #135.

China Universal Asset Management Company first reported a position in SMMT in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.17M in Q2 2025. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • China Universal Asset Management Company held 133,527 shares of Summit Therapeutics worth $1.95M as of Q2 2026.
  • China Universal Asset Management Company sold 4,069 Summit Therapeutics shares in Q2 2026, an estimated $72.2K.
  • Summit Therapeutics made up 0.12% of China Universal Asset Management Company's portfolio in Q2 2026, its #135 holding.
  • China Universal Asset Management Company first reported a position in Summit Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Summit Therapeutics position peaked at $3.17M in Q2 2025.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.